| Literature DB >> 35663006 |
Ahmed Elghoudi1, Hassib Narchi2.
Abstract
Food allergy in children is a major health concern, and its prevalence is rising. It is often over-diagnosed by parents, resulting occasionally in unnecessary exclusion of some important food. It also causes stress, anxiety, and even depression in parents and affects the family's quality of life. Current diagnostic tests are useful when interpreted in the context of the clinical history, although cross-sensitivity and inability to predict the severity of the allergic reactions remain major limitations. Although the oral food challenge is the current gold standard for making the diagnosis, it is only available to a small number of patients because of its requirement in time and medical personnel. New diagnostic methods have recently emerged, such as the Component Resolved Diagnostics and the Basophil Activation Test, but their use is still limited, and the latter lacks standardisation. Currently, there is no definite treatment available to induce life-long natural tolerance and cure for food allergy. Presently available treatments only aim to decrease the occurrence of anaphylaxis by enabling the child to tolerate small amounts of the offending food, usually taken by accident. New evidence supports the early introduction of the allergenic food to infants to decrease the incidence of food allergy. If standardised and widely implemented, this may result in decreasing the prevalence of food allergy. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.Entities:
Keywords: Allergens; Anaphylaxis; Basophil activation test; Desensitisation; Eosinophilic gastrointestinal diseases; Histamine; Immunoglobulin E; Mast cells; Oral food challenge; Oral immunotherapy
Year: 2022 PMID: 35663006 PMCID: PMC9134150 DOI: 10.5409/wjcp.v11.i3.253
Source DB: PubMed Journal: World J Clin Pediatr ISSN: 2219-2808
World Allergy Organization systemic allergic reaction grading system
|
|
|
|
|
|
|
| One organ system involved (cutaneous, respiratory, ocular or others) | Two organ systems involved, or lower respiratory tract involvement, gastrointestinal involvement, or uterine cramping | ||||
| Cutaneous | Generalised pruritus, urticaria, flushinor a sensation of heat or warmth, or angioedema not involving laryngeal, tongue, or uvular tissues. Localised hives or angioedema alone are not considered anaphylaxis | ||||
| Respiratory | Upper respiratory tract symptoms: sneezing, rhinorrhea, nasal pruritus and nasal congestion, throat clearing, itchy throat, and coughing | Lower respiratory tract symptoms: wheezing, shortness of breath. And a drop of 40% in the forced expiratory volume in one second (FEV1) and which responds to bronchodilators | Symptoms of laryngeal, uvular, or tongue tissue oedema. With or without stridor. Or FEV1 drops by 40% with no response to bronchodilators | Respiratory failure | |
| Cardiovascular | Hypotension | ||||
| Gastrointestinal | Abdominal cramping, vomiting or diarrhoea | ||||
| Conjunctival | Conjunctival erythema, pruritus, or tearing | ||||
| Other | Nausea, metallic taste, or headache | Uterine cramping | Death |